Please enable JavaScript to continue using this application.

Compare $HUMA vs $XGN | Chartloom

Compare

$HUMA vs $XGN

Humacyte Inc · Exagen Inc

HUMA

Humacyte Inc

XGN

Exagen Inc

Compare $HUMA vs $XGN

Comparing Humacyte Inc and Exagen Inc

HUMAHumacyte Inc

XGNExagen Inc

HUMAHumacyte Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.62x

Rev growth (TTM)

159.3%

YTD performance

-58.4%

52W performance

-76.0%

FCF yield

-89.3%

XGNExagen Inc

Market cap

$203M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.63x

Rev growth (TTM)

20.8%

YTD performance

39.4%

52W performance

-23.3%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HUMA

XGN

Detailed metrics comparison

HUMA

Humacyte Inc

XGN

Exagen Inc

Market Cap

HUMA$109M

XGN$203M

Enterprise Value

HUMA$96M

XGN$204M

Price

HUMA$0.41

XGN$8.42

P/E Ratio

HUMAN/A

XGNN/A

P/S Ratio

HUMA51.53x

XGN2.86x

EV/Sales

HUMA45.06x

XGN2.87x

EV/EBITDA

HUMA0.00x

XGN0.00x

P/B Ratio

HUMA4.63x

XGN16.60x

P/FCF Ratio

HUMAN/A

XGNN/A

EV/FCF

HUMA-0.98x

XGN-26.94x

PEG Ratio

HUMAN/A

XGNN/A

Forward P/E (NTM)

HUMAN/A

XGNN/A

Forward P/S (NTM)

HUMA14.62x

XGN2.63x

Revenue (TTM)

HUMA$2M

XGN$71M

Revenue Growth (YoY)

HUMA159.3%

XGN20.8%

Forward Rev Growth

HUMA520.3%

XGN10.1%

Gross Margin (TTM)

HUMA-494.6%

XGN58.6%

Operating Margin (TTM)

HUMA0.0%

XGN0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

XGN-15.1%

Net Margin (TTM)

HUMA-4560.8%

XGN-26.6%

FCF Margin (TTM)

HUMA-4599.7%

XGN-10.7%

Net Income (TTM)

HUMA$-97M

XGN$-19M

FCF (TTM)

HUMA$-98M

XGN$-8M

EPS (TTM)

HUMA-$0.41

XGN-$0.78

ROE (TTM)

HUMA-51675.0%

XGN-12162.0%

ROA (TTM)

HUMA-8476.0%

XGN-3368.0%

ROIC (TTM)

HUMA-9784.0%

XGN-4566.0%

Cash

HUMA$80M

XGN$25M

Debt

HUMA$66M

XGN$26M

Net Cash/Debt

HUMA$14M

XGN$-959K

Current Ratio (TTM)

HUMA6.21x

XGN3.18x

Quick Ratio (TTM)

HUMA5.38x

XGN2.75x

Debt/Equity (TTM)

HUMA2.12x

XGN2.09x

Debt/Assets (TTM)

HUMA0.0%

XGN0.0%

Interest Coverage (TTM)

HUMAN/A

XGNN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

XGN0.00x

Beta

HUMA2.76

XGN2.28

52W Performance

HUMA-76.0%

XGN-23.3%

YTD Performance

HUMA-58.4%

XGN39.4%

% from 52W High

HUMA-78.6%

XGN-31.2%

% from 52W Low

HUMA3.7%

XGN225.1%

Asset Turnover (TTM)

HUMA0.02x

XGN1.27x

FCF Yield (TTM)

HUMA-89.3%

XGN-3.7%

Earnings Yield (TTM)

HUMA-88.5%

XGN-9.3%

Dividend Yield (TTM)

HUMAN/A

XGNN/A

Rule of 40

HUMA-4,440.4

XGN10.2

EV/GP/RG

HUMAN/A

XGN0.55

Ticker research

View HUMA research View XGN research

Metric	HUMA Humacyte Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$109M	$203M
Enterprise Value	$96M	$204M
Price	$0.41	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	2.86x
EV/Sales	45.06x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	2.63x
Revenue & Growth
Revenue (TTM)	$2M	$71M
Revenue Growth (YoY)	159.3%	20.8%
Forward Rev Growth	520.3%	10.1%
Profitability
Gross Margin (TTM)	-494.6%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	-15.1%
Net Margin (TTM)	-4560.8%	-26.6%
FCF Margin (TTM)	-4599.7%	-10.7%
Net Income (TTM)	$-97M	$-19M
FCF (TTM)	$-98M	$-8M
EPS (TTM)	-$0.41	-$0.78
ROE (TTM)	-51675.0%	-12162.0%
ROA (TTM)	-8476.0%	-3368.0%
ROIC (TTM)	-9784.0%	-4566.0%
Financial Health
Cash	$80M	$25M
Debt	$66M	$26M
Net Cash/Debt	$14M	$-959K
Current Ratio (TTM)	6.21x	3.18x
Quick Ratio (TTM)	5.38x	2.75x
Debt/Equity (TTM)	2.12x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	2.28
52W Performance	-76.0%	-23.3%
YTD Performance	-58.4%	39.4%
% from 52W High	-78.6%	-31.2%
% from 52W Low	3.7%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	1.27x
FCF Yield (TTM)	-89.3%	-3.7%
Earnings Yield (TTM)	-88.5%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	10.2
EV/GP/RG	N/A	0.55
Ticker research	View HUMA research	View XGN research

Valuation

P/S Ratio

XGN

2.86x

HUMA

51.53x

EV/FCF

XGN

-26.94x

HUMA

-0.98x

Growth & revenue

Revenue Growth TTM

HUMA

159.3%

XGN

20.8%

Forward Revenue Growth

HUMA

520.3%

XGN

10.1%

Profitability & performance

Gross Margin

XGN

58.6%

HUMA

-494.6%

ROE

XGN

-12162.0%

HUMA

-51675.0%

FCF Yield %

XGN

-3.7%

HUMA

-89.3%

52-Week Performance

XGN

-23.3%

HUMA

-76.0%

Detailed metrics comparison

HUMA

Humacyte Inc

XGN

Exagen Inc

Market Cap

HUMA$109M

XGN$203M

Enterprise Value

HUMA$96M

XGN$204M

Price

HUMA$0.41

XGN$8.42

P/E Ratio

HUMAN/A

XGNN/A

P/S Ratio

HUMA51.53x

XGN2.86x

EV/Sales

HUMA45.06x

XGN2.87x

EV/EBITDA

HUMA0.00x

XGN0.00x

P/B Ratio

HUMA4.63x

XGN16.60x

P/FCF Ratio

HUMAN/A

XGNN/A

EV/FCF

HUMA-0.98x

XGN-26.94x

PEG Ratio

HUMAN/A

XGNN/A

Forward P/E (NTM)

HUMAN/A

XGNN/A

Forward P/S (NTM)

HUMA14.62x

XGN2.63x

Revenue (TTM)

HUMA$2M

XGN$71M

Revenue Growth (YoY)

HUMA159.3%

XGN20.8%

Forward Rev Growth

HUMA520.3%

XGN10.1%

Gross Margin (TTM)

HUMA-494.6%

XGN58.6%

Operating Margin (TTM)

HUMA0.0%

XGN0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

XGN-15.1%

Net Margin (TTM)

HUMA-4560.8%

XGN-26.6%

FCF Margin (TTM)

HUMA-4599.7%

XGN-10.7%

Net Income (TTM)

HUMA$-97M

XGN$-19M

FCF (TTM)

HUMA$-98M

XGN$-8M

EPS (TTM)

HUMA-$0.41

XGN-$0.78

ROE (TTM)

HUMA-51675.0%

XGN-12162.0%

ROA (TTM)

HUMA-8476.0%

XGN-3368.0%

ROIC (TTM)

HUMA-9784.0%

XGN-4566.0%

Cash

HUMA$80M

XGN$25M

Debt

HUMA$66M

XGN$26M

Net Cash/Debt

HUMA$14M

XGN$-959K

Current Ratio (TTM)

HUMA6.21x

XGN3.18x

Quick Ratio (TTM)

HUMA5.38x

XGN2.75x

Debt/Equity (TTM)

HUMA2.12x

XGN2.09x

Debt/Assets (TTM)

HUMA0.0%

XGN0.0%

Interest Coverage (TTM)

HUMAN/A

XGNN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

XGN0.00x

Beta

HUMA2.76

XGN2.28

52W Performance

HUMA-76.0%

XGN-23.3%

YTD Performance

HUMA-58.4%

XGN39.4%

% from 52W High

HUMA-78.6%

XGN-31.2%

% from 52W Low

HUMA3.7%

XGN225.1%

Asset Turnover (TTM)

HUMA0.02x

XGN1.27x

FCF Yield (TTM)

HUMA-89.3%

XGN-3.7%

Earnings Yield (TTM)

HUMA-88.5%

XGN-9.3%

Dividend Yield (TTM)

HUMAN/A

XGNN/A

Rule of 40

HUMA-4,440.4

XGN10.2

EV/GP/RG

HUMAN/A

XGN0.55

Ticker research

View HUMA research View XGN research

Metric	HUMA Humacyte Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$109M	$203M
Enterprise Value	$96M	$204M
Price	$0.41	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	2.86x
EV/Sales	45.06x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	2.63x
Revenue & Growth
Revenue (TTM)	$2M	$71M
Revenue Growth (YoY)	159.3%	20.8%
Forward Rev Growth	520.3%	10.1%
Profitability
Gross Margin (TTM)	-494.6%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	-15.1%
Net Margin (TTM)	-4560.8%	-26.6%
FCF Margin (TTM)	-4599.7%	-10.7%
Net Income (TTM)	$-97M	$-19M
FCF (TTM)	$-98M	$-8M
EPS (TTM)	-$0.41	-$0.78
ROE (TTM)	-51675.0%	-12162.0%
ROA (TTM)	-8476.0%	-3368.0%
ROIC (TTM)	-9784.0%	-4566.0%
Financial Health
Cash	$80M	$25M
Debt	$66M	$26M
Net Cash/Debt	$14M	$-959K
Current Ratio (TTM)	6.21x	3.18x
Quick Ratio (TTM)	5.38x	2.75x
Debt/Equity (TTM)	2.12x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	2.28
52W Performance	-76.0%	-23.3%
YTD Performance	-58.4%	39.4%
% from 52W High	-78.6%	-31.2%
% from 52W Low	3.7%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	1.27x
FCF Yield (TTM)	-89.3%	-3.7%
Earnings Yield (TTM)	-88.5%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	10.2
EV/GP/RG	N/A	0.55
Ticker research	View HUMA research	View XGN research